Skip to main content

Table 4 Documented preventive and treatment measures for patients identified with CI by the clinical staff

From: Impact of a dementia-friendly program on detection and management of patients with cognitive impairment and delirium in acute-care hospital units: a controlled clinical trial design

Characteristics

Control

N = 60

Intervention

N = 57

P-value1

Documented measures in the EMR

 n (%)

27 (45.0)

44 (77.2)

 < 0.001

 Orientation

5 (8.3)

14 (24.6)

0.016

 Nutrition and hydration

2 (3.3)

14 (24.6)

0.001

 Elimination

3 (5.0)

10 (17.5)

0.030

 Stabilized vital abnormalities

1 (1.7)

1 (1.8)

0.971

 Mobilization

2 (3.3)

11 (19.3)

0.005

 Sleep hygiene

2 (3.3)

12 (21.1)

0.003

 Pain management

0

4 (7.0)

0.038

 Family involvement

2 (3.3)

24 (42.1)

 < 0.001

 Medications review

3 (5.0)

1 (1.8)

0.326

 Primary nursing

2 (3.3)

3 (5.3)

0.608

 Single room

6 (10.0)

2 (3.5)

0.156

 Referral to cognitive assessment

12 (20.0)

5 (8.8)

0.078

 Other follow-up related to suspicion of CI

12 (20.3)

31 (54.4)

 < 0.001

 Number of measures, mean (SD)

0.9 (1.4)

2.3 (2.1)

 < 0.0012

  1. 1Patients identified with CI by the clinical staff was defined as either a positive 4AT score screened by clinical staff (in the intervention group only) and/or as a description in the EMR indicating a CI/delirium (in control group and as a supplement to screening in intervention group), 2P-value for χ2-test unless otherwise specified, 3P-values for independent samples t-test